Vanda Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ US9216591084

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Mihael Hristos Polymeropoulos. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi
Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Mihael Hristos Polymeropoulos telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:VNDA / Vanda Pharmaceuticals Inc. President and CEO, Director 2,335,731
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Mihael Hristos Polymeropoulos. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam VNDA / Vanda Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam VNDA / Vanda Pharmaceuticals Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan		 Harga
Dilaporkan		 Saham
Dilaraskan		 Harga
Dilaraskan		 Asas Kos Hari ke
Maks		 Harga pada
Maks		 Maks
Keuntungan ($)		 Pulangan Maks (%)
2025-08-07 VNDA Polymeropoulos Mihael Hristos 10,000 4.1500 10,000 4.1500 41,500 15 4.7500 6,000 14.46
2025-05-21 VNDA Polymeropoulos Mihael Hristos 9,519 4.4000 9,519 4.4000 41,884
2025-05-21 VNDA Polymeropoulos Mihael Hristos 481 4.3900 481 4.3900 2,112
2025-05-16 VNDA Polymeropoulos Mihael Hristos 20,000 4.2236 20,000 4.2236 84,472
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5,000 5.0200 5,000 5.0200 25,100
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5,000 5.0100 5,000 5.0100 25,050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5,000 5.0100 5,000 5.0100 25,050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5,000 5.0300 5,000 5.0300 25,150
2025-03-03 VNDA Polymeropoulos Mihael Hristos 10,000 4.7050 10,000 4.7050 47,050
2025-02-28 VNDA Polymeropoulos Mihael Hristos 10,000 4.7600 10,000 4.7600 47,600
2025-02-27 VNDA Polymeropoulos Mihael Hristos 10,000 4.7600 10,000 4.7600 47,600
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5,000 4.7500 5,000 4.7500 23,750
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5,000 4.7800 5,000 4.7800 23,900
2025-02-25 VNDA Polymeropoulos Mihael Hristos 10,000 4.4640 10,000 4.4640 44,640
2011-08-23 VNDA Polymeropoulos Mihael Hristos 7,920 5.3476 7,920 5.3476 42,353
2011-08-22 VNDA Polymeropoulos Mihael Hristos 2,080 5.3423 2,080 5.3423 11,112

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Jualan Orang Dalam VNDA / Vanda Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam VNDA / Vanda Pharmaceuticals Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan		 Harga
Dilaporkan		 Saham
Dilaraskan		 Harga
Dilaraskan		 Asas Kos Hari ke
Min		 Harga pada
Min		 Kerugian Maks
Dielakkan ($)		 Kerugian Maks
Dielakkan (%)
2024-03-05 VNDA Polymeropoulos Mihael Hristos 24,288 4.1285 24,288 4.1285 100,273 13 3.7500 -9,193 -9.17
2024-03-04 VNDA Polymeropoulos Mihael Hristos 30,884 4.2438 30,884 4.2438 131,066
2023-03-03 VNDA Polymeropoulos Mihael Hristos 22,538 6.2506 22,538 6.2506 140,876
2023-03-02 VNDA Polymeropoulos Mihael Hristos 22,426 6.2302 22,426 6.2302 139,718
2022-12-06 VNDA Polymeropoulos Mihael Hristos 48,250 10.6131 48,250 10.6131 512,082
2022-12-05 VNDA Polymeropoulos Mihael Hristos 47,650 10.6233 47,650 10.6233 506,200
2022-03-02 VNDA Polymeropoulos Mihael Hristos 29,588 11.1513 29,588 11.1513 329,945
2022-03-01 VNDA Polymeropoulos Mihael Hristos 7,508 11.1900 7,508 11.1900 84,015
2021-12-01 VNDA Polymeropoulos Mihael Hristos 46,200 16.0032 46,200 16.0032 739,348
2021-11-30 VNDA Polymeropoulos Mihael Hristos 50,000 16.4855 50,000 16.4855 824,275
2021-03-08 VNDA Polymeropoulos Mihael Hristos 175,000 18.0003 175,000 18.0003 3,150,052
2021-03-02 VNDA Polymeropoulos Mihael Hristos 15,206 18.3416 15,206 18.3416 278,902
2021-03-01 VNDA Polymeropoulos Mihael Hristos 7,479 18.4520 7,479 18.4520 138,003
2020-12-15 VNDA Polymeropoulos Mihael Hristos 39,150 12.9973 39,150 12.9973 508,844
2020-12-14 VNDA Polymeropoulos Mihael Hristos 51,049 13.1894 51,049 13.1894 673,306
2020-12-11 VNDA Polymeropoulos Mihael Hristos 35,053 12.8765 35,053 12.8765 451,360
2020-03-03 VNDA Polymeropoulos Mihael Hristos 5,152 10.9752 5,152 10.9752 56,544
2020-03-02 VNDA Polymeropoulos Mihael Hristos 10,428 10.5688 10,428 10.5688 110,211
2020-01-02 VNDA Polymeropoulos Mihael Hristos 9,467 16.0022 9,467 16.0022 151,493
2019-12-12 VNDA Polymeropoulos Mihael Hristos 70,036 16.9820 70,036 16.9820 1,189,351
2019-12-11 VNDA Polymeropoulos Mihael Hristos 72,373 16.9176 72,373 16.9176 1,224,377
2019-05-21 VNDA Polymeropoulos Mihael Hristos 72,872 15.3413 72,872 15.3413 1,117,951
2019-05-20 VNDA Polymeropoulos Mihael Hristos 67,418 15.1159 67,418 15.1159 1,019,084
2019-05-17 VNDA Polymeropoulos Mihael Hristos 77,225 15.5609 77,225 15.5609 1,201,691
2019-03-04 VNDA Polymeropoulos Mihael Hristos 38,166 19.4100 38,166 19.4100 740,802
2019-03-01 VNDA Polymeropoulos Mihael Hristos 6,500 20.2190 6,500 20.2190 131,424
2019-01-03 VNDA Polymeropoulos Mihael Hristos 4,447 26.0410 4,447 26.0410 115,804
2019-01-02 VNDA Polymeropoulos Mihael Hristos 7,733 26.3220 7,733 26.3220 203,548
2019-01-02 VNDA Polymeropoulos Mihael Hristos 3,056 26.9340 3,056 26.9340 82,310
2018-03-01 VNDA Polymeropoulos Mihael Hristos 60,966 18.7154 60,966 18.7154 1,141,003
2018-01-02 VNDA Polymeropoulos Mihael Hristos 170,225 15.2958 170,225 15.2958 2,603,728
2018-01-02 VNDA Polymeropoulos Mihael Hristos 21,535 15.2960 21,535 15.2960 329,399
2017-01-03 VNDA Polymeropoulos Mihael Hristos 23,330 15.4840 23,330 15.4840 361,242
2016-01-04 VNDA Polymeropoulos Mihael Hristos 21,353 8.9600 21,353 8.9600 191,323
2015-09-10 VNDA Polymeropoulos Mihael Hristos 102,162 12.7298 102,162 12.7298 1,300,502
2015-09-09 VNDA Polymeropoulos Mihael Hristos 29,577 12.5092 29,577 12.5092 369,985
2015-05-22 VNDA Polymeropoulos Mihael Hristos 169,238 10.3644 169,238 10.3644 1,754,050
2015-05-21 VNDA Polymeropoulos Mihael Hristos 17,157 10.3332 17,157 10.3332 177,287
2015-03-10 VNDA Polymeropoulos Mihael Hristos 21,900 10.5300 21,900 10.5300 230,607
2013-11-19 VNDA Polymeropoulos Mihael Hristos 8,928 12.0726 8,928 12.0726 107,784
2012-02-16 VNDA Polymeropoulos Mihael Hristos 11,350 4.6920 11,350 4.6920 53,254

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Mihael Hristos Polymeropoulos seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah		 Saham
harga		 Tran
Nilai		 Baki
Nilai
2025-08-08 2025-08-07 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 10,000 2,335,731 0.43 4.15 41,500 9,693,284
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 481 2,325,731 0.02 4.39 2,112 10,209,959
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 9,519 2,325,250 0.41 4.40 41,884 10,231,100
2025-05-19 2025-05-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 20,000 2,315,731 0.87 4.22 84,472 9,780,721
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,295,731 0.22 5.01 25,050 11,501,612
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,290,731 0.22 5.02 25,100 11,499,470
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,285,731 0.22 5.03 25,150 11,497,227
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,280,731 0.22 5.01 25,050 11,426,462
2025-03-04 2025-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 10,000 2,275,731 0.44 4.70 47,050 10,707,314
2025-03-04 2025-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		F - Taxes -95,999 2,265,731 -4.06 4.76 -456,955 10,784,880
2025-02-28 2025-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 10,000 2,361,730 0.43 4.76 47,600 11,241,835
2025-02-27 2025-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 10,000 2,351,730 0.43 4.76 47,600 11,194,235
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,341,730 0.21 4.78 23,900 11,193,469
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 5,000 2,336,730 0.21 4.75 23,750 11,099,468
2025-02-25 2025-02-25 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 10,000 2,331,730 0.43 4.46 44,640 10,408,843
2025-02-20 2025-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 450,000 2,321,730 24.04
2024-03-06 2024-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -24,288 1,871,730 -1.28 4.13 -100,273 7,727,437
2024-03-06 2024-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -30,884 1,896,018 -1.60 4.24 -131,066 8,046,321
2024-02-21 2024-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 450,000 1,926,902 30.47
2023-03-06 2023-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -22,538 1,476,902 -1.50 6.25 -140,876 9,231,524
2023-03-06 2023-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -22,426 1,499,440 -1.47 6.23 -139,718 9,341,811
2023-02-21 2023-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 115,000 1,521,866 8.17
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -48,250 1,406,866 -3.32 10.61 -512,082 14,931,210
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 75,365 1,455,116 5.46 3.12 235,139 4,539,962
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -47,650 1,379,751 -3.34 10.62 -506,200 14,657,509
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 74,635 1,427,401 5.52 3.12 232,861 4,453,491
2022-03-02 2022-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -29,588 1,352,766 -2.14 11.15 -329,945 15,085,099
2022-03-02 2022-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -7,508 1,382,354 -0.54 11.19 -84,015 15,468,541
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Stock Option (Right to Buy) 		A - Award 275,000 275,000
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 115,000 1,389,862 9.02
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -71,676 0 -100.00
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -46,200 1,274,862 -3.50 16.00 -739,348 20,401,872
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 71,676 1,321,062 5.74 4.88 349,779 6,446,783
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -78,324 71,676 -52.22
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -50,000 1,249,386 -3.85 16.49 -824,275 20,596,753
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 78,324 1,299,386 6.41 4.88 382,221 6,341,004
2021-03-09 2021-03-08 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -175,000 1,221,062 -12.54 18.00 -3,150,052 21,979,482
2021-03-03 2021-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -15,206 1,396,062 -1.08 18.34 -278,902 25,606,011
2021-03-03 2021-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -7,479 1,411,268 -0.53 18.45 -138,003 26,040,717
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 275,000 275,000
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 115,000 1,418,747 8.82
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -46,663 0 -100.00
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -39,150 1,303,747 -2.92 13.00 -508,844 16,945,191
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 46,663 1,342,897 3.60 8.75 408,301 11,750,349
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -61,520 46,663 -56.87
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -51,049 1,296,234 -3.79 13.19 -673,306 17,096,549
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 61,520 1,347,283 4.78 8.75 538,300 11,788,726
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -41,817 108,183 -27.88
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -35,053 1,285,763 -2.65 12.88 -451,360 16,556,127
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 41,817 1,320,816 3.27 8.75 365,899 11,557,140
2020-03-04 2020-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -5,152 1,278,999 -0.40 10.98 -56,544 14,037,270
2020-03-04 2020-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -10,428 1,284,151 -0.81 10.57 -110,211 13,571,935
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 140,000 140,000
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 60,000 1,294,579 4.86
2020-01-06 2020-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -9,467 1,234,579 -0.76 16.00 -151,493 19,755,980
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -85,801 0 -100.00
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -70,036 1,244,046 -5.33 16.98 -1,189,351 21,126,389
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 85,801 1,314,082 6.99 10.65 913,781 13,994,973
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -89,199 85,801 -50.97
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -72,373 1,228,281 -5.56 16.92 -1,224,377 20,779,567
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 89,199 1,300,654 7.36 10.65 949,969 13,851,965
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -79,019 0 -100.00
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -72,872 1,211,455 -5.67 15.34 -1,117,951 18,585,295
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 79,019 1,284,327 6.56 12.55 991,688 16,118,304
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -73,608 79,019 -48.23
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -67,418 1,205,308 -5.30 15.12 -1,019,084 18,219,315
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 73,608 1,272,726 6.14 12.55 923,780 15,972,711
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -97,373 152,627 -38.95
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -77,225 1,199,118 -6.05 15.56 -1,201,691 18,659,355
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 97,373 1,276,343 8.26 12.55 1,222,031 16,018,105
2019-03-04 2019-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -38,166 1,178,970 -3.14 19.41 -740,802 22,883,808
2019-03-04 2019-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -6,500 1,217,136 -0.53 20.22 -131,424 24,609,273
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 140,000 140,000
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 60,000 1,223,636 5.16
2019-01-04 2019-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -4,447 1,163,636 -0.38 26.04 -115,804 30,302,245
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -3,056 1,168,083 -0.26 26.93 -82,310 31,461,148
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -7,733 1,171,139 -0.66 26.32 -203,548 30,826,721
2019-01-04 2018-12-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		G - Gift -4,000 1,178,872 -0.34
2018-03-02 2018-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -60,966 1,182,872 -4.90 18.72 -1,141,003 22,137,923
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 140,000 140,000
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		A - Award 60,000 1,243,838 5.07
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 37,500 -33.33
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 12,500 -50.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 12,500 -50.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -250,000 0 -100.00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -21,535 1,183,838 -1.79 15.30 -329,399 18,107,986
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 1,205,373 1.58
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 1,149,123 1.10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 1,149,123 1.10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -170,225 1,111,623 -13.28 15.30 -2,603,728 17,003,163
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 250,000 1,281,848 24.23 5.76 1,440,000 7,383,444
2018-01-04 2017-12-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		G - Gift -10,000 1,031,848 -0.96
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 275,000 275,000
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		A - Award 200,000 1,041,848 23.76
2017-02-06 2016-12-23 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		G - Gift -9,000 830,178 -1.07
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 56,250 -25.00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 25,000 -33.33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 25,000 -33.33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -6,250 0 -100.00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -23,330 850,848 -2.67 15.48 -361,242 13,174,530
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 874,178 2.19
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 855,428 1.48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 855,428 1.48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 6,250 830,428 0.76
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		A - Award 75,000 75,000
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 175,000 175,000
2016-02-12 2015-12-28 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		G - Gift -15,000 801,781 -1.84
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 25,000 -33.33
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -6,250 6,250 -50.00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -21,353 839,178 -2.48 8.96 -191,323 7,519,035
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 860,531 1.47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 860,531 1.47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 848,031 1.50
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 6,250 835,531 0.75
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -147,626 0 -100.00
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -102,162 816,781 -11.12 12.73 -1,300,502 10,397,459
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 147,626 918,943 19.14 4.73 698,271 4,346,600
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -42,747 147,626 -22.45
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -29,577 771,317 -3.69 12.51 -369,985 9,648,559
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 42,747 800,894 5.64 4.73 202,193 3,788,229
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -359,815 0 -100.00
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -169,238 758,147 -18.25 10.36 -1,754,050 7,857,739
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 359,815 927,385 63.40 0.33 119,099 306,964
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -35,806 359,815 -9.05
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -17,157 567,570 -2.93 10.33 -177,287 5,864,814
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 35,806 584,727 6.52 0.33 11,852 193,545
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -6,250 12,500 -33.33
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 12,500 -50.00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -21,900 548,921 -3.84 10.53 -230,607 5,780,138
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 570,821 2.24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 6,250 558,321 1.13
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		M - Exercise -48,154 0 -100.00
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		F - Taxes -24,947 527,071 -4.52 11.28 -281,402 5,945,361
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 48,154 552,018 9.56 0.03 1,594 18,272
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units 		A - Award 50,000 50,000
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 150,000 150,000
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units 		M - Exercise -6,250 18,750 -25.00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units 		M - Exercise -12,500 25,000 -33.33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units 		M - Exercise -12,500 25,000 -33.33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 0 -100.00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		F - Taxes -17,772 503,864 -3.41 13.46 -239,211 6,782,009
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 6,250 521,636 1.21
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 515,386 2.49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 515,386 2.49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 490,386 3.98
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		A - Award 50,000 50,000
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 150,000 150,000
2013-11-21 2013-11-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -8,928 471,636 -1.86 12.07 -107,784 5,693,873
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -25,000 25,000 -50.00
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 25,000 480,564 5.49
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 18,750 -50.00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		F - Taxes -16,836 455,564 -3.56 3.95 -66,502 1,799,478
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 472,400 2.72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 472,400 2.72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 447,400 4.37
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		A - Award 50,000 50,000
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) 		A - Award 150,000 150,000
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -12,500 37,500 -25.00
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 37,500 -33.33
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		S - Sale -11,350 428,650 -2.58 4.69 -53,254 2,011,226
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 12,500 440,000 2.92
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 427,500 4.59
2012-02-13 2011-08-23 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 7,920 408,750 1.98 5.35 42,353 2,185,832
2012-02-13 2011-08-22 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock 		P - Purchase 2,080 400,830 0.52 5.34 11,112 2,141,354
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit 		M - Exercise -18,750 56,250 -25.00
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock 		M - Exercise 18,750 408,750 4.81
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)